Covenant Partners, LLC Astrazeneca PLC Transaction History

Covenant Partners, LLC

$337 Million
Q3 2024

A detailed history of Covenant Partners, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Covenant Partners, LLC holds 13,925 shares of AZN stock, worth $909,998. This represents 0.32% of its overall portfolio holdings.

Number of Shares

13,925

Previous 13,924 0.01%

Holding current value

$909,998

Previous $1.09 Million -0.0%

% of portfolio

0.32%

Previous 0.34%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$76.67 - $87.62 $76 - $87	1 Added 0.01%	13,925 $1.09 Million
Q2 2024 Aug 05, 2024	BUY	$66.81 - $80.83 $146,113 - $176,775	2,187 Added 18.63%	13,924 $1.09 Million
Q1 2024 Apr 30, 2024	BUY	$61.03 - $69.57 $2,013 - $2,295	33 Added 0.28%	11,737 $795,000
Q4 2023 Feb 20, 2024	SELL	$61.89 - $69.28 $304,870 - $341,273	-4,926 Reduced 29.62%	11,704 $788,000
Q3 2023 Oct 20, 2023	SELL	$64.85 - $71.7 $207,584 - $229,511	-3,201 Reduced 16.14%	16,630 $1.13 Million
Q2 2023 Aug 11, 2023	SELL	$69.91 - $75.81 $190,155 - $206,203	-2,720 Reduced 12.06%	19,831 $1.42 Million
Q1 2023 Apr 19, 2023	SELL	$63.15 - $71.6 $2,968 - $3,365	-47 Reduced 0.21%	22,551 $1.57 Million
Q3 2022 Nov 10, 2022	BUY	$53.02 - $135.75 $563,284 - $1.44 Million	10,624 Added 88.73%	22,598 $1.24 Million
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $135,901 - $163,705	2,439 Added 25.58%	11,974 $794,000
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $529,764 - $579,632	9,535 New	9,535 $573,000
Q3 2020 Nov 10, 2020	SELL	$53.07 - $61.1 $426,205 - $490,694	-8,031 Closed	0 $0
Q2 2020 Aug 17, 2020	SELL	$43.1 - $55.31 $141,712 - $181,859	-3,288 Reduced 29.05%	8,031 $425,000
Q1 2020 May 15, 2020	SELL	$37.79 - $51.33 $296,575 - $402,837	-7,848 Reduced 40.95%	11,319 $506,000
Q4 2019 Feb 14, 2020	SELL	$42.46 - $50.46 $214,040 - $254,368	-5,041 Reduced 20.82%	19,167 $956,000
Q3 2019 Nov 14, 2019	BUY	$40.12 - $45.47 $202,244 - $229,214	5,041 Added 26.3%	24,208 $1.08 Million
Q2 2019 Aug 15, 2019	BUY	$37.28 - $41.68 $66,060 - $73,856	1,772 Added 10.19%	19,167 $791,000
Q1 2019 May 16, 2019	BUY	$35.49 - $43.02 $617,348 - $748,332	17,395 New	17,395 $703,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covenant Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Covenant Partners, LLC with notifications on news.

Account

Covenant Partners, LLC Astrazeneca PLC Transaction History